ATE46083T1 - Arzneimittel zur topischen anwendung. - Google Patents

Arzneimittel zur topischen anwendung.

Info

Publication number
ATE46083T1
ATE46083T1 AT86307195T AT86307195T ATE46083T1 AT E46083 T1 ATE46083 T1 AT E46083T1 AT 86307195 T AT86307195 T AT 86307195T AT 86307195 T AT86307195 T AT 86307195T AT E46083 T1 ATE46083 T1 AT E46083T1
Authority
AT
Austria
Prior art keywords
compositions
topical application
medications
topical use
nicotinate
Prior art date
Application number
AT86307195T
Other languages
English (en)
Inventor
Martin Whitefield
Original Assignee
Diomed Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diomed Dev Ltd filed Critical Diomed Dev Ltd
Application granted granted Critical
Publication of ATE46083T1 publication Critical patent/ATE46083T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT86307195T 1985-09-18 1986-09-18 Arzneimittel zur topischen anwendung. ATE46083T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858523036A GB8523036D0 (en) 1985-09-18 1985-09-18 Pharmaceutical composition
EP86307195A EP0220825B1 (de) 1985-09-18 1986-09-18 Arzneimittel zur topischen Anwendung

Publications (1)

Publication Number Publication Date
ATE46083T1 true ATE46083T1 (de) 1989-09-15

Family

ID=10585343

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86307195T ATE46083T1 (de) 1985-09-18 1986-09-18 Arzneimittel zur topischen anwendung.

Country Status (5)

Country Link
EP (1) EP0220825B1 (de)
AT (1) ATE46083T1 (de)
DE (1) DE3665403D1 (de)
ES (1) ES2000398A6 (de)
GB (2) GB8523036D0 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87390A1 (fr) * 1988-11-17 1990-06-12 Oreal Utilisation du nicotinate d'alpha-tocopherol et/ou du nicotinate d'hexyle dans une composition cosmetique a action amincissante

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB620687A (en) * 1945-05-22 1949-03-29 Winthrop Chem Co Inc Improvements in or relating to alkyl esters of nicotinic acid
US2431558A (en) * 1945-05-22 1947-11-25 Winthrop Stearns Inc Vasodilator compositions comprising alkyl nicotinates
FR1593M (fr) * 1960-11-16 1962-12-03 Kabi Ab Compositions pour le traitement de l'acne.

Also Published As

Publication number Publication date
GB8523036D0 (en) 1985-10-23
EP0220825B1 (de) 1989-09-06
GB2184652A (en) 1987-07-01
ES2000398A6 (es) 1988-02-16
GB2184652B (en) 1989-08-23
EP0220825A2 (de) 1987-05-06
GB8622487D0 (en) 1986-10-22
DE3665403D1 (en) 1989-10-12
EP0220825A3 (en) 1987-09-09

Similar Documents

Publication Publication Date Title
MX9304710A (es) Composicion farmaceutica y/o cosmetica y su uso.
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
ATE169228T1 (de) Verbesserung der durchdringungfähigkeit von topischen anwendbaren formulierungen
ATE181231T1 (de) Verfahren zur hautpflege und mittel
RU93047799A (ru) Композиции, содержащие ретиноевые кислоты и токоферол
TR26721A (tr) Jel tipi kozmetik bilesimler
DK357386D0 (da) Saarhelende midler
DE69033731D1 (de) Depigmentierendes pharmazeutisches oder kosmetisches mittel mit kaffeinsäure
DE3785684D1 (de) Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung.
ES2040257T3 (es) Composicion cosmetica.
BR9403783A (pt) Uso de uma composição cosmética
DE69917858D1 (de) Gebrauch von Silicongummi zur Stabilisierung von Ascorbinsaüre und Vorbereitungen die diese Zusammensetzungen enthalten
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
IT8520970A0 (it) Composizione farmaceutica in crema per uso dermale ed oftalmico.
DE59101214D1 (de) Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich.
ATE71304T1 (de) Zusammensetzung zur herstellung unmittelbar vor dem gebrauch von pharmazeutischen und kosmetischen formulierungen zur topischen anwendung.
DE58902582D1 (de) Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe.
ATE46083T1 (de) Arzneimittel zur topischen anwendung.
ZA91115B (en) Topical compositions
ATE5073T1 (de) 5-amino-tetrazol-derivate von retinsaeuren, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE3484355D1 (de) Gefaerbte wasserfreie mittel fuer kosmetische, medizinische und aehnliche zwecke, sowie deren herstellung.
ITMI912466A1 (it) Uso di 1, 2 dipalmitoil-l-alfa-fosfatidil-n, n-dimetiletanolammina, in composizioni dermatologiche
EP0190860A3 (de) 6-Chloro-3-methyl-1H-2,3,4,5-tetrahydro-3-benzazepin-N-oxyd und dieses enthaltende Arzneimittel
DE68910021D1 (de) Oxaminsäureverbindungen und pharmazeutische Zusammensetzungen zur Anwendung bei der Verbesserung geschädigter Hirnfunktionen.
ATE56362T1 (de) Arzneimittel zur externen anwendung enthaltend aktives vitamin-d3.